Ashley Yocum, PhD, is the executive research strategy lead of the Beat AML Master Trial at the Leukemia & Lymphoma Society.
Global Hematology Experts Reflect on Key Takeaways From the EHA 2025 Congress
At the 30th European Hematology Association (EHA) Congress, hematology experts highlight breakthroughs in treatment, the importance of patient voices, and challenges in making innovations accessible worldwide.
Beat AML Master Trial Expands Precision Medicine Options for Patients With AML: Ashley Yocum, PhD
At the European Hematology Association (EHA) 2025 Congress, Ashley Yocum, PhD, highlights how the Beat AML Master Trial advances safe, personalized treatment and expands targeted therapy options for patients with acute myeloid leukemia (AML).